Found 14 matching trials
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NATo compare between efficacy of phosphodiesterase5 inhibitors (tadalafil 5 m...
Location
Multiple Locations
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
PHASE4The purpose of this study is to evaluate the clinical efficacy of alpha-blo...
Location
Soon Chun Hyang University Hospital Cheonan
Fesoterodine "add-on" Male Overactive Bladder Study
PHASE3To evaluate the efficacy and safety of fesoterodine on overactive bladder s...
Location
Pfizer Investigational Site
Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
PHASE4This study is designed to investigate the comparison between alpha blocker ...
Location
Samsung Medical Center
A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder
PHASE4The purpose of this study is to explore additional benefit of solifenacin a...
Location
Multiple Locations
Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
PHASE4The purpose of this study is to determine whether combination therapy with ...
Location
University of Wisconsin
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NAThe study objective is to compare water vapor thermotherapy with the REZŪM™...
Status
Active Not Recruiting
Location
Epworth Healthcare
Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan
N/AThis retrospective study aims to assess treatment patterns within 1 year of...
Location
Multiple Locations
Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH
PHASE3The investigators compare the efficacy of alpha-blocker and 5-ARI withdrawa...
Location
Gangnam Severance Hospital, Yonsei University College of Medicine
Detrol LA In Men With Overactive Bladder.
PHASE4An interventional active/placebo double blinded parallel randomized control...
Location
Pfizer Investigational Site